PR Team at Ubie, Inc.
Ubie Inc. (Headquarters: Chuo-ku, Tokyo; Co-CEOs: Yoshinori Abe and Kota Kubo) are pleased to announce that former Prime Minister and Member of the House of Representatives, Fumio Kishida, will deliver the keynote speech at the Ubie Pharma Summit 2025, a two-day conference for pharmaceutical companies to be held on May 14th (Wed) and 15th (Thu).
About the Ubie Pharma Summit
"Ubie Pharma Summit" is Japan's largest conference for pharmaceutical companies, with over 1,000 participants from the pharmaceutical industry. It aims to contribute to the further development of the industry by providing a forum for sharing information and exchanging opinions on the industry's mid to long-term challenges and specific solutions. The fourth "Ubie Pharma Summit" will be held at two venues, Tokyo and Osaka, with the theme of "Patient-Centric Impacts" - creating business and social impacts with a patient-centered approach.
Ubie Pharma Summit 2024
Keynote Speech
Lecture theme: The future of Japan's healthcare policy and expectations for the pharmaceutical industry
Keynote Speaker: Mr. Fumio Kishida, Former Prime Minister and Member of the House of Representatives
Overview of "Ubie Pharma Summit 2025"
Event Dates (may be some variation):
Day 1: Wednesday, May 14, 2025 1:30pm-6:00pm + social gathering
Day 2: Thursday, May 15, 2025 10:30am-6:00pm + Social gathering
Venues:
Tokyo: Toranomon Hills Forum
Osaka: TBA (scheduled to be held around Umeda Station)
Participation fee: Free
Organized by: Ubie Pharma Summit 2025 Executive Committee
This event will be held in-person (there are currently no plans to stream it online)
Simultaneous English interpretation will be available (we will create an experience that English-only speakers can also participate in)
There is no lottery system. (In principle, we ask that those other than pharmaceutical companies refrain from participating.)
About Ubie
Ubie is a health tech company with the mission of leveraging technology to guide people to the appropriate care. Our consumer service "Ubie" helps over 12 million people access appropriate medical care each month. "Ubie Medical Navigator" for healthcare institutions supports improving the quality of medical consultations in over 1,700 medical institutions nationwide, while "Ubie for Pharma" maximizes prescription opportunities in collaboration with pharmaceutical companies.
Since its founding in 2017, Ubie's contributions through business activities, in collaboration with stakeholders, are estimated to have extended healthy life expectancy by over 27,000 years and created an economic value exceeding 150 billion yen. Additionally, Ubie established a U.S. subsidiary in 2022 and is working on expanding its presence there.
Learn more about our vision and work at https://ubiehealth.com/company or try our free Symptom Checker at https://ubiehealth.com/.
View original press release in Japanese here: https://prtimes.jp/main/html/rd/p/000000119.000048083.html
SOURCE Ubie, Inc.